Safety and Short-term Efficacy of a Single Dose of 2 mg Moxidectin in Loa loa -Infected Individuals: A Double-Blind, Randomized Ivermectin-Controlled Trial With Ascending Microfilarial Densities.

Guy S WafeuTristan M LepageJeremy T CampilloArnauld Efon-EkangouoHugues-Clotaire Nana-DjeungaNarcisse Nzune-TocheAndré DomcheLaurentine SumoGuy-Roger NjitchouangMartine Augusta Flore TsasseJean BopdaYves Aubin BalogYannick Niamsi-EmalioStève Mbickmen-TchanaGervais Kamga TallaYannick Sédrick Nguedia KanaFélicité Diane Maga MessinaSébastien D PionAnnette C KueselJoseph KamgnoMichel BoussinesqCedric B Chesnais

Published in: Open forum infectious diseases (2024)

NCT04049851.

Keyphrases

double blind
open label
placebo controlled
phase iii
clinical trial
phase ii
study protocol
pulmonary artery
aortic dissection
pulmonary hypertension
pulmonary arterial hypertension